Skip to main content
. 2022 Feb 2;6(3):920–930. doi: 10.1182/bloodadvances.2021005899

Figure 1.

Figure 1.

Transplantation outcomes. Cumulative incidence of chronic GVHD (A), NRM (B) and relapse (C). Probability of PFS (D), OS (E), and GRFS (F). ATG, anti-thymocyte globulin; Haplo, haplo-HCT; MU, matched unrelated donor.